Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $20,244 - $30,360
429 Added 4.9%
9,181 $623,000
Q4 2022

Feb 14, 2023

SELL
$30.35 - $53.15 $2.39 Million - $4.18 Million
-78,722 Reduced 89.99%
8,752 $433,000
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $2.8 Million - $4.32 Million
87,474 New
87,474 $2.84 Million
Q2 2022

Aug 15, 2022

SELL
$35.61 - $76.23 $176,589 - $378,024
-4,959 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$57.56 - $82.54 $372,701 - $534,446
-6,475 Reduced 56.63%
4,959 $347,000
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $1.12 Million - $1.56 Million
-15,512 Reduced 57.57%
11,434 $890,000
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $2.43 Million - $3.34 Million
26,946 New
26,946 $2.57 Million
Q1 2021

May 17, 2021

SELL
$116.57 - $155.01 $4.23 Million - $5.62 Million
-36,256 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $3.61 Million - $5.15 Million
36,256 New
36,256 $4.8 Million
Q2 2020

Aug 14, 2020

SELL
$55.75 - $92.75 $387,351 - $644,427
-6,948 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$37.9 - $104.44 $263,329 - $725,649
6,948 New
6,948 $403,000
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $4.48 Million - $5.75 Million
-57,690 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $5.21 Million - $7.07 Million
57,690 New
57,690 $5.21 Million
Q2 2019

Aug 14, 2019

SELL
$89.51 - $118.04 $2.87 Million - $3.79 Million
-32,103 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $1.99 Million - $3.1 Million
32,103 New
32,103 $2.78 Million
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $3.7 Million - $6.17 Million
-76,583 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$37.84 - $69.96 $1.94 Million - $3.6 Million
51,400 Added 204.11%
76,583 $4.58 Million
Q1 2018

May 15, 2018

BUY
$39.82 - $57.53 $789,471 - $1.14 Million
19,826 Added 370.1%
25,183 $1.02 Million
Q4 2017

Feb 14, 2018

BUY
$46.49 - $60.51 $249,046 - $324,152
5,357
5,357 $281,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.